PL2727912T3 - Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne - Google Patents

Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne

Info

Publication number
PL2727912T3
PL2727912T3 PL12804465T PL12804465T PL2727912T3 PL 2727912 T3 PL2727912 T3 PL 2727912T3 PL 12804465 T PL12804465 T PL 12804465T PL 12804465 T PL12804465 T PL 12804465T PL 2727912 T3 PL2727912 T3 PL 2727912T3
Authority
PL
Poland
Prior art keywords
crystals
pharmaceutical use
glycine derivative
glycine
derivative
Prior art date
Application number
PL12804465T
Other languages
English (en)
Inventor
Motohiro Shiraki
Hirozumi Takahashi
Tsutomu Nogami
Original Assignee
Toray Industries, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toray Industries, Inc. filed Critical Toray Industries, Inc.
Publication of PL2727912T3 publication Critical patent/PL2727912T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/42—One nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PL12804465T 2011-06-30 2012-06-29 Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne PL2727912T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2011145446 2011-06-30
PCT/JP2012/066672 WO2013002364A1 (ja) 2011-06-30 2012-06-29 グリシン誘導体の結晶及びその医薬用途
EP12804465.8A EP2727912B1 (en) 2011-06-30 2012-06-29 Crystals of glycine derivative and pharmaceutical use thereof

Publications (1)

Publication Number Publication Date
PL2727912T3 true PL2727912T3 (pl) 2017-12-29

Family

ID=47424249

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12804465T PL2727912T3 (pl) 2011-06-30 2012-06-29 Kryształy pochodnej glicyny i ich zastosowanie farmaceutyczne

Country Status (13)

Country Link
US (1) US9006434B2 (pl)
EP (1) EP2727912B1 (pl)
JP (1) JP5998933B2 (pl)
KR (1) KR20140027944A (pl)
CN (1) CN103619823B (pl)
AU (1) AU2012276650B2 (pl)
CA (1) CA2837453C (pl)
DK (1) DK2727912T3 (pl)
ES (1) ES2633179T3 (pl)
PL (1) PL2727912T3 (pl)
PT (1) PT2727912T (pl)
UA (1) UA111213C2 (pl)
WO (1) WO2013002364A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPWO2014051056A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 グリシン誘導体の結晶及びその医薬用途
JP7233829B2 (ja) 2016-12-27 2023-03-07 東京製綱株式会社 鋼管杭式土砂崩壊予防施設及び鋼管杭式土砂崩壊予防施設の形成方法
JP7337724B2 (ja) 2020-02-14 2023-09-04 大成建設株式会社 半地下タンク構造

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL63968A (en) 1980-10-01 1985-10-31 Glaxo Group Ltd Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
WO1999001444A1 (en) 1997-07-02 1999-01-14 Merck & Co., Inc. Polymorphic form of the tachykinin receptor antagonist 2-(r)-(1-(r) -(3,5-bis(trifluoromethyl) phenyl)ethoxy)-3-(s)-(4-fluoro) phenyl-4-(3-5 (-oxo-1h,4h-1,2,4,-triazolo) methylmorpholine
ES2390281T3 (es) * 2004-12-24 2012-11-08 Toray Industries, Inc. Derivado de glicina y uso del mismo
JP5115478B2 (ja) 2006-06-14 2013-01-09 東レ株式会社 アレルギー性皮膚炎の治療又は予防剤
CN101472900B (zh) * 2006-06-19 2011-07-27 东丽株式会社 多发性硬化症的治疗或预防药
KR101353879B1 (ko) 2006-06-20 2014-01-20 도레이 카부시키가이샤 백혈병의 치료 또는 예방제
JPWO2014051056A1 (ja) * 2012-09-28 2016-08-22 東レ株式会社 グリシン誘導体の結晶及びその医薬用途

Also Published As

Publication number Publication date
JPWO2013002364A1 (ja) 2015-02-23
CA2837453C (en) 2017-04-11
KR20140027944A (ko) 2014-03-07
ES2633179T3 (es) 2017-09-19
EP2727912A1 (en) 2014-05-07
JP5998933B2 (ja) 2016-09-28
PT2727912T (pt) 2017-07-25
CN103619823B (zh) 2016-01-20
US20140128605A1 (en) 2014-05-08
EP2727912B1 (en) 2017-04-19
WO2013002364A1 (ja) 2013-01-03
CA2837453A1 (en) 2013-01-03
AU2012276650A1 (en) 2014-01-23
AU2012276650B2 (en) 2016-06-23
UA111213C2 (uk) 2016-04-11
CN103619823A (zh) 2014-03-05
US9006434B2 (en) 2015-04-14
DK2727912T3 (en) 2017-07-17
EP2727912A4 (en) 2014-12-10

Similar Documents

Publication Publication Date Title
HK1258536A1 (zh) 用於誘導組織再生的肽及其應用
HK1215948A1 (zh) 醯胺及其醫藥用途
HK1199892A1 (en) Modified mini-hepcidin peptides and methods of using thereof
IL228925A0 (en) Benzothiazole compounds and their pharmaceutical use
PL2683731T3 (pl) C4-monometylowe pochodne triterpenoidów i sposoby ich zastosowania
EP2739144A4 (en) COMPOUNDS AND ITS THERAPEUTIC USE
EP2788020A4 (en) THERAPEUTIC USE OF ANTI-CD22 ANTIBODIES FOR THE INDUCTION OF TROGO CYTOSIS
EP2772483A4 (en) 4-AMINOCARBAZOLE COMPOUND AND USE THEREOF
ZA201401653B (en) Pyrazol-4yl-heterocyclyl-carboxamide compounds and methods of use
ZA201401071B (en) Pyrazole compound and pharmaceutical use thereof
EP2718283A4 (en) INDAZOLE AND PYRROLOPYRIDINE DERIVATIVE AND PHARMACEUTICAL USE THEREOF
EP2709999A4 (en) QUINAZOLINE-7-ETHER COMPOUNDS AND METHODS OF USE
EP2727912A4 (en) GLYCIN DERIVATIVE CRYSTALS AND THEIR PHARMACEUTICAL USE
GB201112578D0 (en) Pharmaceutical preparation and use
PT3199533T (pt) Composto de pirazol e a sua utilização farmacêutica
GB201104632D0 (en) Use of medicament